1
13
34
45
39
37
44
47
40
57
32
31
26
24
35
23
39
25
Fosso B, Pesole G, Rosselló F, Valiente G.
Unbiased Taxonomic Annotation of Metagenomic Samples. J Comput Biol. (2018) 25(3):348-360.
Bellomo F, Signorile A, Tamma G, Ranieri M, Emma F, De Rasmo D.
Impact of atypical mitochondrial cyclic-AMP level in Nephropathic Cystinosis. Cell Mol Life Sci. (2018)
Celestini V, Tezil T, Russo L, Fasano C, Sanese P, Forte G, Peserico A, Lepore Signorile M, De Rasmo D, Signorile A, Gadaleta R, Scialpi N, Terao M, Garattini E, Cocco T, Villani G, Moschetta A, Gross Gi, Simone C.
Uncoupling FoxO3A mitochondrial and nuclear functions in cancer cells undergoing metabolic stress and chemotherapy. Cell Death Dis. (2018) 9:231.
Valenti D, Braidy N, De Rasmo D, Signorile A, Rossi L, Atanasov AG, Volpicella M, Henrion-Caude A, Nabavi SM, Vacca RA
Mitochondria as pharmacological targets in Down syndrome. Free Radic. Biol. Med. (2018) 114:69-83.
M. Chiara, S. Gioiosa, G. Chillemi, M. D'Antonio, T. Flati, E. Picardi, F. Zambelli, D. S. Horner, G. Pesole, T. Castrignanò
CoVaCS: a Consensus Variant Calling System. (2018). BMC Genomics, 19:120. doi: 10.1186/s12864-018-4508-1.
Valenti D, Braidy N, De Rasmo D, Signorile A, Rossi L, Atanasov AG, Volpicella M, Henrion-Caude A, Nabavi SM, Vacca RA
Mitochondria as pharmacological targets in Down syndrome. Free Radic. Biol. Med. (2018) 114:69-83.
Santamaria M, Fosso B, Licciulli F, Balech B, Larini I, Grillo G, De Caro G, Liuni S, Pesole G.
ITSoneDB: a comprehensive collection of eukaryotic ribosomal RNA Internal Transcribed Spacer 1 (ITS1) sequences. Nucleic Acids Res. (2018) 46(D1):D127-D132
Carmona-Gutierrez D, Bauer MA, Zimmermann A........ Giannattasio S......... Guaragnella N.... Kroemer G, Madeo F
Guidelines and recommendations on yeast cell death nomenclature. Microbial Cell (2018): vol.5 N.1.
Tewari D, Nabavi SF, Nabavi SM, Sureda A, Farooqi AA, Atanasov AG, Vacca RA, Sethi G, Bishayee A
Targeting activator protein 1 signaling pathway by bioactive natural agents: Possible therapeutic strategy for cancer prevention and intervention. Pharmacol. Res. (2018) 128:366-375.